EFA participated in the European Academy of Allergy and Clinical Immunology (EAACI) Congress, celebrated in Lisbon from 1st to 5th June. The Congress is the biggest world allergy forum in the world, and this year it focused on Precision Medicine. EFA President Mikaela Odemyr brought the patients’ perspective into one of the symposia in the scientific programme dedicated to ethics.
EFA President Mikaela Odemyr made the patient voice heard
Most importantly, we made the patient voice heard: EFA President, Mikaela Odemyr has been a speaker in the ethics session. Focusing on ethical aspects of the use and prescription of Adrenaline auto-injectors (AAIs), she explained the psychological impact of prescribing AAIs on patients. Further, she pinpoined prescription of adrenaline entials many things going beyond being diagnosed at high risk of food allergy accident, such as high costs and loss of personal flexibility.
The full presentation can be accessed here.
Scientific programme focusing on Precision Medicine
This years’ overall topic was ‘Precision Medicine’. The scientific programme was developed to provide delegates with new knowledge on allergen structure, aerobiology, disease endotypes, biologicals, genomics, proteomics and metabolomics.
A great possibility to meet, greet and connect
With more than 7,000 delegates attending, the Congress was also an opportunity to familiarise with organisations and stakeholders who have an impact in the world of allergy and immunology, apart from pharmaceutical companies. The National Society Village gave visibility to medical societies from Europe but also to patient groups like EFA and our international sister organisation GAAPP (Global Allergy and Asthma Patient Platform).
Visitors to our booth could meet the EFA team and get copies of our report ITCHING FOR LIFE – Quality of Life and costs for people with severe atopic eczema in Europe, as well as EFA Annual Report 2018 and the brochures of the European Parliament Interest Group on Asthma and Allergy.
